Disclosure of large shareholding in Gentian Diagnotics ASA

03 Mar 2025 10:12 CET

Gentian Diagnostics ASA - Disclosure of Large Shareholding
Oslo, Norway, March 3, 2025

Insr ASA and Norda ASA have today acquired in total 1,228,502 shares (614,251
shares each) in Gentian Diagnostics ASA at an average price of NOK 46.5 per
share. Insr ASA and Norda ASA will together with the Group of companies Kvantia
AS, Obligasjon 2 AS, Caaby AS, RWD AS and Victoria India Fund AS following the
share transactions hold in total 3,422,370 shares in Gentian Diagnostics ASA,
corresponding to approx. 22.2% of the total outstanding shares.

More information:
Access the news on Oslo Bors NewsWeb site